{
    "nctId": "NCT00776659",
    "briefTitle": "An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin",
    "officialTitle": "An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 39,
    "primaryOutcomeMeasure": "Number of Participants With Locoregional/Distant Recurrence of Primary Breast Cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with early breast cancer receiving adjuvant therapy with Aromasin\u00ae will be eligible.\n\nExclusion Criteria:\n\n* Patients presenting with in situ cancers, recurrent or metastatic breast cancer, or a 2nd primary will not be included.\n* Patients with a known hypersensitivity to Exemestane or its metabolites will also not be included.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}